CAGR: 12.5%Current Market Size: USD 1.9 BillionFastest Growing Region: APAC
Largest Market: North AmericaProjection Time: 2023-2030Base Year: 2022
The global medical affairs outsourcing market is expected to grow from USD 1.9 billion in 2022 to USD 5.48 billion by 2030, at a CAGR of 12.5% during the Projection period 2023-2030. The growth of the medical affairs outsourcing market is mainly driven by the rise in government initiatives.
Medical affairs outsourcing is a procedure that gives patients, medical staff, and governmental organisations extensive knowledge about healthcare practises, procedures, and patient information. It offers affordable and adaptable solutions to deal with the common problems the industry has and enables original equipment manufacturers (OEMs) to make the best use of healthcare resources, strategic management, and resource components. Finding existing pharmacological indications and launching new and inventive products are made easier with the help of medical affairs outsourcing. As a result, it is employed by pharmaceutical, biotechnology, and medical device businesses to effectively complete the pre- and post-production phases as well as clinical trials of medical products. Medical affairs outsourcing is currently being used by numerous healthcare businesses throughout the world to successfully comply with the strict regulatory standards of various nations. Currently, one of the main factors positively affecting the market is the rising number of clinical trials around the world as a result of the growing elderly population and the rising prevalence of different communicable and non-communicable disorders. Clinical trials assist in determining the safety requirements and effectiveness of a therapy approach, medications, and equipment. New medications and medical devices are also being developed at an increased rate. This is currently fueling a global demand for medical affairs outsourcing services, along with improvements in medical education and the prevalence of orphan treatments used to treat uncommon diseases. Aside from this, the outlook for the market is good due to rising healthcare expenditures and governments in various nations focusing on enhancing healthcare infrastructure.
Sample Request: - Global Medical Affairs Outsourcing Market
Market Dynamics:
Drivers:
A positive market view is being provided by the rising propensity of many medical, pharmaceutical, biotechnological, medical device, and diagnostic industries to outsource medical services and goods in order to diversify their business operations and sustain the product life cycle. Medical affairs outsourcing is being encouraged by changing customer desires for specialist medications in order to produce complex patient outcomes data related to specialty therapy areas. Additionally, as more drugs enter the pipeline, there is a rising demand for tailored medical affairs outsourcing in the biotherapeutics sector in order to reallocate resources and optimize commercial prospects, which is anticipated to fuel market expansion.
Restraints:
The problem of data and privacy breaches has been a constant worry for all industries. As technology advances, criminal brains have grown increasingly creative in finding new ways to steal. More than 15 million patient records were exposed in 2018 alone. Therefore, it is essential to pick an IT vendor for healthcare providers who can guarantee the protection of patient data and is in compliance with the Health Insurance Portability and Accountability Act (HIPAA). There are always dangers involved with commercial ventures, and the healthcare sector is no exception. Hospitals and other healthcare providers benefit more from outsourcing if they know how to reduce the risks they are incurring and pick their vendors carefully.
Opportunities:
This is a direct outcome of the decreased accessibility to healthcare facilities and HCPs. Many stakeholders, including physician societies, have started expanding virtual scientific engagements & medical education programs, frequently in collaboration with the industry, to ensure that HCPs are educated about new & upcoming technology. This transformation has been aided by the creation of virtual distribution channels and the launch of new platforms like Zoom. Additionally, MSL teams now conduct one-on-one virtual consultations with experts and key opinion leaders to obtain insights and disseminate scientific data. This new form of communication has been warmly welcomed by healthcare professionals, who also see its suitability and value.
Challenges:
The likelihood of encountering quality problems is something else that outsourcers must take into account. Poor quality frequently results from miscommunications over the extent of the work being done and the total cost of those services. Healthcare organizations should not undervalue the time and effort needed to establish a successful outsourcing partnership, particularly in the beginning. Providers and vendors must clearly specify the scope of the work, the metrics and criteria by which it will be evaluated, and the total cost for any scenario that could be mutually agreed upon. Both parties can reduce the likelihood of misunderstandings by making SLAs the cornerstone of their agreement by clearly specifying the services to be provided and the standards of performance.
Segmentation Analysis:
The global medical affairs outsourcing market has been segmented based on services, industry, and region.
By Services
The services segment is medical monitoring, medical information, medical writing & publishing, medical science liaisons, and others. The medical writing & publishing segment led the largest share of the medical affairs outsourcing market with a market share of around 42.3% in 2022. The sector with the biggest income share was medical writing and publication, which was the most promising. Currently, the majority of pharmaceutical businesses use professional medical writing and publishing service providers to manage their clinical data. The need for qualified medical writers is anticipated to rise dramatically as more pharmaceutical goods are released onto the market. For instance, the European Medical Writers Association (EMWA) stated that it will upgrade its Medical Writing session (formerly Internship Forum) in September 2021 as a result of the recent establishment of the Getting into Medical Writing (GIMW) group. This group's mission is to help new EMWA members successfully and smoothly begin their careers as medical writers.
By Industry
The industry segment is medical devices and pharma & biopharmaceuticals. The pharma & biopharmaceuticals segment led the largest share of the medical affairs outsourcing market with a market share of around 60.3% in 2022. The need for medical affairs service providers has increased as a result of several patent expirations for the creation of new patent draughts. The global pandemic is expected to have a long-term impact on the pharmaceutical business, which has been experiencing poor growth, delayed medication approvals, and an insufficient pharma production supply chain.
Global Medical Affairs Outsourcing Market - Sales Analysis.
The sale of the medical affairs outsourcing market expanded at a CAGR of 11.2% from 2016 to 2022.
Due to the increase in clinical studies, the market is expanding significantly. According to information released by the WHO in 2019, there were 54,894 clinical studies registered annually, up from 3,344 in 2004. Thus, from 2004 to 2018, the registration of clinical trials grew by around 22%. The growing number of medical affairs is projected to drive the global market for medical affairs outsourcing over the Projection period because it is a crucial support activity for a successful clinical trial. Additionally, pharmaceutical and medical device companies are outsourcing medical affairs services to Contract Research Organizations (CROs) in order to reduce operational costs, minimize regulatory compliance risk, avoid process delays, and limit liability exposure by working with a well-trained outsource company.
Outsourcing medical affairs services to Contract Research Organizations (CROs) to reduce operating costs, eliminate regulatory compliance risk, and prevent process delays by working with a skilled outsourcing organization is a major factor influencing the growth of the global market for pharmaceutical and medical device businesses. Additionally, more clinical studies are being conducted as a result of the rising occurrence of rare illnesses worldwide, which is fueling the market's expansion. For instance, the United Kingdom (UK) filed 290 patent applications in the pharmaceutical sector in 2020, according to data from the European Patent Office published in March 2021.
Thus, owing to the aforementioned factors, the global medical affairs outsourcing market is expected to grow at a CAGR of 12.5% during the Projection period from 2023 to 2030.
By Regional Analysis:
The regions analyzed for the medical affairs outsourcing market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America region dominated the medical affairs outsourcing market and held a 38.2% share of the market revenue in 2022.
Global Medical Affairs Outsourcing Market - Country Analysis:
Germany's medical affairs outsourcing market size was valued at USD 0.75 billion in 2022 and is expected to reach USD 1.19 billion by 2030, at a CAGR of 6% from 2023 to 2030. In 2020, 274 biopharmaceutical pharmaceuticals were in clinical phase I, 261 in phase II, and 122 in phase III in Germany, according to the BCG - Medizinische Biotechnologie in Deutschland updated in June 2021.
China’s medical affairs outsourcing market size was valued at USD 0.78 billion in 2022 and is expected to reach USD 1.26 billion by 2030, at a CAGR of 6.2% from 2023 to 2030. The region's medical affairs market is anticipated to increase over the course of the Projection period as a result of the presence of numerous organizations, the cost advantages of outsourcing medical affairs, and the knowledge needed for medical affairs.
India's medical affairs outsourcing market size was valued at USD 0.60 billion in 2022 and is expected to reach USD 0.96 billion by 2030, at a CAGR of 6.1% from 2023 to 2030. Because the area has a knowledgeable and experienced medical affairs team. Furthermore, due to the region's CROs' ability to provide services at a reasonable price, the India region is predicted to have the highest growth throughout the Projection period.
Key Industry Players Analysis:
To increase their market position in the global medical affairs outsourcing market business, top companies focus on tactics such as adopting new technology, mergers & acquisitions, product developments, collaborations, partnerships, joint ventures, etc.
Latest Development:
Report Metrics
Report Attribute |
Details |
Study Period |
2022-2030 |
Base year |
2022 |
CAGR (%) |
12.5% |
Market Size |
1.9 billion in 2022 |
Projection period |
2023-2030 |
Projection unit |
Value (USD) |
Segments covered |
By Services, By Industry, and By Region. |
Report Scope |
Revenue Projection, competitive landscape, company ranking, growth factors, and trends |
Companies covered |
ICON plc, The Medical Affairs Company, IQVIA Holdings, Inc., Pharmaceutical Product Development, LLC, Syneos Health, Inc., Zeincro Group, Ashfield Healthcare Communications, Wuxi Clinical Development, Inc., SGS S.A., and Indegene, Inc. |
By Services |
|
By Industry |
|
Regional scope |
|
Scope of the Report
Global Medical Affairs Outsourcing Market By Services:
Global Medical Affairs Outsourcing Market By Industry:
Global Medical Affairs Outsourcing Market By Region:
Global medical affairs outsourcing market is expected to reach USD 5.48 billion by 2030.
The medical affairs outsourcing market is projected to have a CAGR of 12.5%.
Based on the services, the medical affairs outsourcing market is segmented into medical monitoring, medical information, medical writing & publishing, medical science liaisons, and others.
Leading market players active in the global medical affairs outsourcing market are ICON plc, Syneos Health Inc, Wuxi Clinical Development, Inc, SGS SA, Ashfield Healthcare Communications, Indegene Inc., Pharmaceutical Product Development, LLC, IQVIA Holdings Inc, The Medical Affairs Company (TMAC), ZEINCRO Group, among other.
A positive market view is being provided by the rising propensity of many medical, pharmaceutical, biotechnological, medical device, and diagnostic industries to outsource medical services and goods in order to diversify their business operations and sustain the product life cycle. Medical affairs outsourcing is being encouraged by changing customer desires for specialist medications in order to produce complex patient outcomes data related to specialty therapy areas. Additionally, as more drugs enter the pipeline, there is a rising demand for tailored medical affairs outsourcing in the biotherapeutics sector in order to reallocate resources and optimize commercial prospects, which is anticipated to fuel market expansion.
Political Factors- Before deciding whether to grow, the medical affairs outsourcing market should carefully research the best taxation policies. Industries that are high on the government's priority list will profit more from tax policy. To entice foreign direct investment, many governments in emerging nations are actively working to reduce corporate taxes. Since these countries have low tax rates, it will be simpler for businesses operating in the medical affairs outsourcing sector to turn a profit and finance R&D, innovation, and new product development initiatives.
Economical Factors- The ability of the medical affairs outsourcing market to increase revenue may be constrained by rising inflation, which weakens the purchasing power of money and discourages consumers from making purchases of goods and services. The profitability of a corporation may be impacted by exchange rate changes. The market for medical affairs outsourcing should be studied in order to accurately predict exchange rate movements and prevent negative effects on trade and business performance. The market for medical affairs outsourcing will have to make interest-only payments due to the high interest rate, which enhances the total cost of the loans taken out.
Social Factor- Consumption patterns and financial issues are closely related. When consumers have more disposable income and are prepared to spend more on products and services to better their lifestyles, the market for medical affairs outsourcing benefits from exciting growth opportunities. This is because providing new goods and services to these customers is simpler, and there are better chances for revenue development. In order to adjust its marketing mix methods, the medical affairs outsourcing sector must carefully evaluate the consumption/spending patterns and preferences of contemporary consumers, who are becoming more picky. The market for baldness must also decide whether consumer behaviour is motivated by hedonistic or utilitarian goals. A critical element of customer behaviour that could have an impact on the success of medical affairs outsourcing is the degree of ethnocentrism.
Technological Factors- Because these nations make it easier for firms to pursue objectives like cost reduction, innovation, and value creation, they should be given preference in the medical affairs outsourcing market. A technological infrastructure that is well-developed also indicates that it will be more challenging for the medical affairs outsourcing market to leverage technology to create a long-term competitive advantage because rivals might easily replicate it. The process of identifying and implementing new goods and services to raise the value of an existing good or service is referred to as "innovation."
Environmental Factors- Because these nations make it easier for firms to pursue objectives like cost reduction, innovation, and value creation, they should be given preference in the medical affairs outsourcing market. A well-developed technological infrastructure indicates that it will be more challenging for the medical affairs outsourcing market to employ technology to create a long-term competitive advantage because rivals may easily replicate it. By making the appropriate technical investments, the medical affairs outsourcing market may enhance customer satisfaction, provide operational savings, and position itself as an innovative organisation.
Legal Factors- A wide variety of rules known as employment law protect a wide range of employee rights, including the right to a decent pay, equality, equity, inclusion, justice, and physical and mental safety. While some nations do not effectively enforce employment regulations, others impose harsh fines for transgressing any of the mentioned employee rights. When entering or operating in these nations, the market for medical affairs outsourcing should take precautions to ensure the security of the workplace. To stop direct and indirect discrimination, appropriate systems must be in place. Effective adherence to employment laws can aid the medical affairs outsourcing market in enhancing its employer brand reputation, which is essential for luring and keeping top talent in today's competitive labour market.
List of Table
List of Figures